Koselugo (selumetinib)
pCPA File Number:
22375
Negotiation Status:
Active Negotiation
Indication(s):
Neurofibromatosis type 1 in pediatric patients aged 2 years and above, who have symptomatic, inoperable plexiform neurofibromas
Sponsor/Manufacturer:
Alexion Pharma GMBH
CDA-AMC Project Number:
SR0764
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable